2010
DOI: 10.1016/j.jcv.2010.03.010
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of QuickVue influenza A+B rapid test for detection of pandemic influenza A/H1N1 2009

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
17
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 21 publications
0
17
0
Order By: Relevance
“…Factors that can impact RIDT performance include specimen type, 7 , 14 time of specimen collection after onset of illness, 7 duration of specimen storage, and transportation conditions. We were not able to compare RIDT performance among different specimen types because 98% of the specimens included in this study were NP swabs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Factors that can impact RIDT performance include specimen type, 7 , 14 time of specimen collection after onset of illness, 7 duration of specimen storage, and transportation conditions. We were not able to compare RIDT performance among different specimen types because 98% of the specimens included in this study were NP swabs.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that RIDT sensitivity was correlated with increasing viral titer 2 , 6 , 7 and that higher RIDT sensitivity was found in younger age groups than older groups 3 , 5 , 8 , 9 . However, these studies were conducted either in pediatric patients or with a small sample of older patients.…”
Section: Introductionmentioning
confidence: 99%
“…1e3 For example, the QuickVue Influenza AþB Test (Quidel, San Diego, CA, USA), which is an enzyme-linked immunosorbent assay (ELISA)-based kit and detects both influenza virus A and influenza virus B, has shown a sensitivity of 0.63 and a specificity of 0.96 with the 2009 pandemic influenza A (H1N1) infection. 4 Most of these rapid tests use monoclonal antibodies against nucleoprotein encoded by influenza A viruses. 5 In this study, we tested a new 2009 pandemic influenza A (H1N1)-specific ELISA 6 designed and manufactured by Xiamen University, China, on human samples.…”
Section: Introductionmentioning
confidence: 99%
“…These tests are widely used in physician offices and hospital laboratories because of their simplicity and speed. RIATs are well known to have poor sensitivity, including for the influenza A (H1N1) 2009 virus (1,4,5,(7)(8)(9)(10). Few studies have reported poor specificity of RIATs (8), and the widely held view is that the specificity and positive predictive value (PPV) of these tests are relatively high when they are performed during periods of high disease prevalence.…”
mentioning
confidence: 99%
“…Most studies have reported relatively high QuickVue RIAT specificities of 84 to 100% and PPV of 84 to 97% for influenza A viruses, including the H1N1 2009 pandemic subtype (4,7,9,10). One recent study reported QuickVue specificity of 46.4% during the influenza A (H1N1) 2009 pandemic, but according to the authors, data may have been skewed by testing algorithms (8).…”
mentioning
confidence: 99%